Scottish Genomes Partnership launched at parliamentary Rare Disease Day

The Scottish Genomes Partnership, led by Professors Tim Aitman (University of Edinburgh) and Andrew Biankin (University of Glasgow) was officially launched on 1st March at a reception hosted by Malcolm Chisholm MSP: March 2016

The Scottish Genomes Partnership, led by Professors Tim Aitman (University of Edinburgh) and Andrew Biankin (University of Glasgow) was officially launched on 1st March at a reception hosted by Malcolm Chisholm MSP to mark Rare Disease Day 2016 at the Scottish Parliament.

Jamie Hepburn MSP, Minister for Sport, Health Improvement and Mental Health announced the £6m investment in the Scottish Genomes Partnership, after which Professor Zosia Miedzybrodzka, the NHS lead for the Scottish Genomes Partnership, spoke about the project and what it means for patients suffering from rare diseases.

Professor Aitman, Co-chair of the SGP and Director of CGEM said:

“This funding creates a unique opportunity to translate the investment of Scottish Universities into immediate healthcare benefits for Scottish patients. The remarkable advances in genome technology over the past five years will now be available to patients in the Scottish NHS, bringing a new dimension of healthcare to Scottish patients with cancer and inherited diseases. We look forward to working with our partners in the Scottish NHS, the Scottish Universities and Genomics England on this landmark project.”